Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunohistochemical Analysis of the Metabolic Phenotype of Adrenal Cortical Carcinoma.

Endocrine pathology - 1 Sept 2020

Duan Kai, Gucer Hasan, Kefeli Mehmet, Asa Sylvia L, Winer Daniel A, Mete Ozgur

Abstract excerpt

Metabolic reprogramming is a cellular process contributing to carcinogenesis. However, it remains poorly understood in adrenal cortical carcinoma (ACC), an aggressive malignancy with overall poor prognosis and limited therapeutic options. We characterized the metabolic phenotype of ACC, by examining the immunoprofile of key proteins involved in glucose metabolism, hexokinase (HK1), pyruvate kinase (PKM1, PKM2),...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Cortex Neoplasms
Share to Adrenocortical Carcinoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cohort Studies

Share to Immunohistochemistry

Share to Metabolome

Share to Phenotype

Share to Proteomics

Share to Tissue Array Analysis

Source

Identifiers

PMID: 32367334
DOI: 10.1007/s12022-020-09624-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunohistochemical Analysis of the Metabolic Phenotype of Adrenal Cortical Carcinoma.PMID 32367334Read ↗

A proteome-based classification of pediatric adrenocortical tumors links functional tumor states to clinical outcome and therapeutic vulnerabilitiesSemantic proximity Read ↗

Update on Biology and Genomics of Adrenocortical Carcinomas: Rationale for Emerging TherapiesSemantic proximity Read ↗

Transcriptome analysis of adrenocortical cancers (ACC): from molecular classification to the identification of new treatmentsSemantic proximity Read ↗

Therapy-Associated Oncogenic Axes of Core Cellular and Metabolic Programs Revealed by Multi-Omics Regulatory Network Analysis in Adrenocortical CarcinomaSemantic proximity Read ↗

Pathological and molecular features of adrenocortical carcinoma: an updateSemantic proximity Read ↗

Heterogeneity of tumor-induced gene expression changes in the human metabolic network.Semantic proximity Read ↗

The expression of PKM1 and PKM2 in developing, benign, and cancerous prostatic tissuesSemantic proximity Read ↗

Aiding Cancer’s “Sweet Tooth”: Role of Hexokinases in Metabolic ReprogrammingSemantic proximity Read ↗

Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomasSemantic proximity Read ↗

Molecular Classification and Prognostication of Adrenocortical Tumors by Transcriptome ProfilingSemantic proximity Read ↗

Pan-Cancer Expression Analysis of the Aminoadipate-semialdehyde synthase (AASS) Gene: Insights into its Potential Role in Oncogenic Metabolic ReprogrammingSemantic proximity Read ↗

Adrenocortical carcinoma: clinical, morphologic, and molecular characterization.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.